INTRODUCTION

Mercury Exposure Assessment
Urine is used to assess elemental mercury exposure and hair is used to assess 127 methylmercury exposure (Berglund et al., 2005; Clarkson and Magos, 2006) . From each 128 participant, spot urine samples (~30-50mL) were collected and stored frozen. Hair was collected 129 by cutting 20-50 strands from the occipital region of the head as close to the scalp as possible, 130 wrapping in paper, and then storing at room temperature.
132
Total mercury levels were measured using a direct mercury analyzer 133 Milestone Inc., CT) according to US EPA Method 7473. Briefly, 800 μL of urine or 4-9 mg of 134 hair from the two cm closest to the scalp were analyzed according to methods we have 135 previously described (Basu et al., 2010; Goodrich et al., 2011; Paruchuri et al., 2010) . In every 136 batch of 10-15 samples, one blank, one replicate sample, and a certified reference material (hair:
137
NIES Japan CRM #13; urine: Institut National de Sante Publique Quebec standard 138 QMEQAS08U-01; dogfish liver: DOLT4, National Research Council Canada) were included.
139
Specific gravity was measured using a refractometer (PAL-10S, Atago U.S.A., Inc., WA). Urine 140 mercury levels were adjusted to reflect the average specific gravity in all samples (1.017) 141 according to the method of Levine and Fahy (1945) as this has been shown to reduce variability 142 in metal analysis of spot urine samples (Lee et al., 1996; Mason and Calder, 1994) . All final 143 values reported here are unadjusted.
145
The average theoretical method detection limit (3x standard deviation of blanks) was 146 0.003 µg/g mercury for hair and 0.014 µg/L mercury for urine. The average recovery of mercury 147 was 88.9±1.1% for the hair CRM, 71.5±3.9% for the mean urine CRM value, and 91.8±6.6% for DOLT4. The mercury value in the urine CRM has a range of expected values, and our percent 149 recovery was judged according to the reported mean. Machine accuracy is deemed high given 150 that recovery of other reference materials (e.g., DOLT4) measured alongside the urine CRM had 151 excellent recovery (>90%). Within-day (0.7% for hair, 4.2% for urine, 2.8% for DOLT4) and 152 between day (1.0% for hair, 5.4% for urine, 6.1% for DOLT4) variability of CRMs were 153 calculated, and these values corresponded well to replicate analysis of actual samples provided 154 by participants (data not shown). 
Statistical Analyses
164
All statistical operations were performed using PASW® Statistics Software (v. 18; 165 Chicago, IL). Preliminary data analysis included tabulation of descriptive statistics for all 166 measurements. Bivariate (Pearson correlations) and multivariate analyses were performed to 167 identify factors that influenced SBP and DBP. Blood pressure measurements of individuals using 168 hypertension controlling medications were imputed 15 mmHg higher (SBP) and 10 mmHg 169 higher (DBP) before linear regression as this has been shown to reduce bias and improve 170 statistical power (Tobin et al., 2005) . All bivariate and multivariate analyses were performed with adjusted and unadjusted SBP and DBP; analyses with the latter excluded subjects using anti-hypertensive medication (n=39).
174
The backward elimination method was used to determine predictors of SBP and DBP
175
(adjusted for medication use) with an initial cut-off significance value of p>0.10. Variables 176 considered in the multivariate models were age, BMI, gender, race, occupation (dentist vs. non-177 dentist), alcohol (drinks/day), fish nutrients/toxicants (PUFA, selenium, mercury) gender was also included in the final model to control for gender differences observed in our 182 population. Hair and urine mercury (together and in separate models, with unadjusted or specific 183 gravity adjusted urine mercury) were added into SBP and DBP base models to assess the 184 association between mercury biomarkers and blood pressure after controlling for confounders.
185
Multivariable linear regression models were run for the total population and for subgroups 186 (males, females, dentists, non-dentists). Potentially influential subjects were identified using 187 statistical diagnostics (e.g. Cook's distance, dfbeta) on total population models, and removed 188 individually to assess the impact of the subject on the relationships between mercury biomarkers 189 and blood pressure. non-dentists), and anti-hypertensive medication usage. Of all participants, 38% were males and 198 44% were dentists. Overall, males were significantly older, had greater BMIs and alcohol 199 consumption compared with females while also having higher blood pressure and lower pulse.
RESULTS
200
Dentists, of which 80% are males, likewise had similar differences compared to non-dentists
201
(dental hygienists, dental assistants and other professionals, of whom 94% were female The urine mercury and blood pressure relationship differed from hair mercury results.
251
Urine mercury levels were associated with decreased SBP (in total population model: β= -1.8 252 mmHg SBP per 1 μg/L Hg in urine), though this was only significant in models adjusting for
253
anti-hypertensive medication use and appeared to be driven by the males and the dentists. Urine 254 mercury was not associated with DBP, though negative trends were also observed among males 255 and dentists. Even though several model parameters were significantly correlated with one 256
another (e.g. BMI and age, hair and urine mercury), multicollinearity is not expected to be 257 problematic as variance inflation factors were less than 1.5 for all aforementioned regression 258 models.
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